Exploring the Therapeutic Potential of Lumnitzera racemosa in an Accelerated Ovarian Failure model of Menopausal Syndrome

Aim: This research aims to assess the therapeutic potential of L. racemosa in an Accelerated Ovarian Failure (AOF) rat model using 4-Vinyl cyclohexene diepoxide (VCD) to mimic menopausal syndrome.Materials and Methods: Six groups of rats were used, with six rats in each group. All animals, except the control group, were administered VCD (160 mg/kg) intraperitoneally. Methanolic extract of L. racemosa leaves were given orally at doses of 100 mg/kg, 250 mg/kg, and 500 mg/kg and one group administered with standard estrogen 110µg/kg. Biochemical & Histopathological parameters were assessed at the end of the study.Results: One-way ANOVA in Graph Pad Prism 10.3.0 was used to analyse results and presented as Mean ± SEM. LDL levels significantly decreased (***P<0.0001) in the 500 mg/kg treatment group compared to the AOF group. The AOF group showed a significant increase in proinflammatory cytokines, while the 500 mg/kg treatment group saw a significant decrease in IL-1β (***P<0.0001), IL-6 (****P<0.0001), and TNF (****P<0.0001). FSH (****P<0.0001) and LH (****P<0.0001) levels significantly increased, but progesterone levels did not (P<0.0001). By the end of the study, the 500 mg/kg treatment group showed a decline in progesterone and estrogen levels compared to all other groups. Serum phosphorus levels showed no significant change (****P<0.0001). The decline in calcium levels in the AOF group was rectified (P=0.7019) in the 250 mg/kg and 500 mg/kg treatment groups. Liver enzyme levels increased in the AOF group but decreased in ALP (***P<0.0001), ALT (***P<0.0001), and AST (P<0.0001) in the 250 mg/kg and 500 mg/kg treatment groups.Conclusion:L.racemosa is a mangrove plant which has wide range of secondary metabolites that are beneficial in reducing hormonal dysregulation. From all the findings we conclude that L.racemosa extract will be the good alternative for Hormonal replacement therapy. Receptor level studies are further required to establish the activity.

Authors

Publication Details

Journal
South Eastern European Journal of Public Health
Published
2025-03-08
DOI
https://doi.org/10.70135/seejph.vi.5624
Primary Topic
Phytochemistry and Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the Therapeutic Potential of Lumnitzera racemosa in an Accelerated Ovarian Failure model of Menopausal Syndrome

G Sumalatha, S Masa, Saraswati Patel, Samriti Faujdar et al.
South Eastern European Journal of Public Health
Phytochemistry and Bioactive Compounds
article

Exploring the Therapeutic Potential of Lumnitzera racemosa in an Accelerated Ovarian Failure model of Menopausal Syndrome

G Sumalatha, S Masa, Saraswati Patel, Samriti Faujdar, Amala Masa, Urvashi Sharma
article en

Abstract

Aim: This research aims to assess the therapeutic potential of L. racemosa in an Accelerated Ovarian Failure (AOF) rat model using 4-Vinyl cyclohexene diepoxide (VCD) to mimic menopausal syndrome.Materials and Methods: Six groups of rats were used, with six rats in each group. All animals, except the control group, were administered VCD (160 mg/kg) intraperitoneally. Methanolic extract of L. racemosa leaves were given orally at doses of 100 mg/kg, 250 mg/kg, and 500 mg/kg and one group administered with standard estrogen 110µg/kg. Biochemical & Histopathological parameters were assessed at the end of the study.Results: One-way ANOVA in Graph Pad Prism 10.3.0 was used to analyse results and presented as Mean ± SEM. LDL levels significantly decreased (***P<0.0001) in the 500 mg/kg treatment group compared to the AOF group. The AOF group showed a significant increase in proinflammatory cytokines, while the 500 mg/kg treatment group saw a significant decrease in IL-1β (***P<0.0001), IL-6 (****P<0.0001), and TNF (****P<0.0001). FSH (****P<0.0001) and LH (****P<0.0001) levels significantly increased, but progesterone levels did not (P<0.0001). By the end of the study, the 500 mg/kg treatment group showed a decline in progesterone and estrogen levels compared to all other groups. Serum phosphorus levels showed no significant change (****P<0.0001). The decline in calcium levels in the AOF group was rectified (P=0.7019) in the 250 mg/kg and 500 mg/kg treatment groups. Liver enzyme levels increased in the AOF group but decreased in ALP (***P<0.0001), ALT (***P<0.0001), and AST (P<0.0001) in the 250 mg/kg and 500 mg/kg treatment groups.Conclusion:L.racemosa is a mangrove plant which has wide range of secondary metabolites that are beneficial in reducing hormonal dysregulation. From all the findings we conclude that L.racemosa extract will be the good alternative for Hormonal replacement therapy. Receptor level studies are further required to establish the activity.

South Eastern European Journal of Public Health
Openalex Percentile: Top 95%
Phytochemistry and Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.